InterCure Ltd. (INCR)
NASDAQ: INCR · Real-Time Price · USD
1.520
-0.070 (-4.40%)
May 12, 2025, 4:00 PM - Market closed
InterCure Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for InterCure.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for InterCure.
Recommendation Trends
Rating | Nov '22 | Dec '22 | Jan '23 | Feb '23 | Mar '23 | Apr '23 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 | 0 |
Buy | 3 | 3 | 3 | 3 | 3 | 0 |
Hold | 4 | 4 | 4 | 4 | 4 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 9 | 9 | 9 | 9 | 9 | 0 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
TD Cowen | TD Cowen | Buy Maintains $10 → $5 | Buy | Maintains | $10 → $5 | +228.95% | Apr 12, 2023 |
Barclays | Barclays | Hold Initiates $40 | Hold | Initiates | $40 | +2,531.58% | Dec 11, 2017 |
Credit Suisse | Credit Suisse | Buy Maintains $68 → $54 | Buy | Maintains | $68 → $54 | +3,452.63% | Nov 14, 2017 |
Keybanc | Keybanc | Buy Maintains $68 → $46 | Buy | Maintains | $68 → $46 | +2,926.32% | Nov 13, 2017 |
Baird | Baird | Buy Maintains $67 → $46 | Buy | Maintains | $67 → $46 | +2,926.32% | Nov 10, 2017 |
Financial Forecast
Revenue This Year
404.94M
from 238.85M
Increased by 69.54%
Revenue Next Year
574.00M
from 404.94M
Increased by 41.75%
EPS This Year
0.59
from -1.48
EPS Next Year
1.70
from 0.59
Increased by 187.93%
Financial currency is ILS. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 |
---|---|---|
High | 416.9M | 590.9M |
Avg | 404.9M | 574.0M |
Low | 389.1M | 551.5M |
Revenue Growth
Revenue Growth | 2025 | 2026 |
---|---|---|
High | 74.5% | 45.9% |
Avg | 69.5% | 41.7% |
Low | 62.9% | 36.2% |
EPS Forecast
EPS | 2025 | 2026 |
---|---|---|
High | 0.61 | 1.75 |
Avg | 0.59 | 1.70 |
Low | 0.57 | 1.64 |
EPS Growth
EPS Growth | 2025 | 2026 |
---|---|---|
High | - | 196.4% |
Avg | - | 187.9% |
Low | - | 176.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.